Opthea Email Format

Biotechnology ResearchVictoria, Australia11-50 Employees

Opthea is an Australian biotechnology company focused on developing health solutions for women. It is pursuing a disease-modifying treatment for lymphangioleiomyomatosis (LAM), a rare condition largely affecting women, by targeting the signaling of VEGF-C and VEGF-D. The lead asset has been studied in approximately 2,000 patients in prior late-stage development, establishing an understanding of its safety and biological activity in humans. The company aims to progress through a focused, capital-efficient clinical program toward proof-of-concept. Opthea is based at 650 Chapel Street, Suite 0403, Level 4, South Yarra, Victoria 3141, Australia, and has 11-50 employees; it trades on the ASX and NASDAQ as OPT and maintains the website https://opthea.com.

Sign up for free to view info

Company overview Employee directory